僅用于工業(yè)應(yīng)用或科學(xué)研究，不可用于人類或動(dòng)物的臨床診斷或治療，非藥用. Patritumab （Human Anti-ERBB3 Recombinant Antibody） is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab （HY-P9905）, potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors